Enzo Biochem (NYSE:ENZ) Coverage Initiated at StockNews.com

Equities research analysts at StockNews.com began coverage on shares of Enzo Biochem (NYSE:ENZ) in a report issued on Friday. The brokerage set a “hold” rating on the medical research company’s stock.

Enzo Biochem Stock Down 3.7 %

Shares of NYSE ENZ opened at $0.68 on Friday. Enzo Biochem has a 1-year low of $0.68 and a 1-year high of $1.44. The business has a 50-day moving average of $0.93 and a 200-day moving average of $1.05.

Enzo Biochem (NYSE:ENZ) last released its quarterly earnings results on Monday, December 16th. The medical research company reported ($0.05) EPS for the quarter. Enzo Biochem had a negative return on equity of 11.84% and a negative net margin of 81.73%.

Hedge Funds Weigh In On Enzo Biochem

A number of institutional investors have recently added to or reduced their stakes in the company. Renaissance Technologies LLC raised its position in shares of Enzo Biochem by 2.6% in the 2nd quarter. Renaissance Technologies LLC now owns 2,499,546 shares of the medical research company’s stock valued at $2,725,000 after purchasing an additional 64,417 shares in the last quarter. XTX Topco Ltd increased its stake in shares of Enzo Biochem by 94.5% in the second quarter. XTX Topco Ltd now owns 28,262 shares of the medical research company’s stock worth $31,000 after buying an additional 13,735 shares during the last quarter. BBR Partners LLC acquired a new stake in Enzo Biochem in the third quarter valued at $112,000. Finally, Geode Capital Management LLC boosted its stake in Enzo Biochem by 3.3% during the 3rd quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock valued at $413,000 after acquiring an additional 11,742 shares during the last quarter. Institutional investors and hedge funds own 36.90% of the company’s stock.

Enzo Biochem Company Profile

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.